278803-18-2 Usage
Uses
Used in Pharmaceutical Industry:
6-PIPERAZIN-1-YL-NICOTINIC ACID is used as a therapeutic agent for its potential to treat neurological and psychiatric disorders. Its agonistic action on specific receptors in the central nervous system makes it a promising candidate for addressing various conditions.
Used in Antifungal Applications:
In the field of antifungal research, 6-PIPERAZIN-1-YL-NICOTINIC ACID is used as an antimicrobial agent to combat fungal infections. Its ability to inhibit fungal growth makes it a valuable compound in the development of new antifungal treatments.
Used in Antimicrobial Applications:
6-PIPERAZIN-1-YL-NICOTINIC ACID is also used as an antimicrobial agent in the medical and pharmaceutical sectors. Its potential to inhibit the growth of bacteria and other microorganisms contributes to its utility in creating new antimicrobial therapies and products.
Check Digit Verification of cas no
The CAS Registry Mumber 278803-18-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,8,8,0 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 278803-18:
(8*2)+(7*7)+(6*8)+(5*8)+(4*0)+(3*3)+(2*1)+(1*8)=172
172 % 10 = 2
So 278803-18-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H13N3O2/c14-10(15)8-1-2-9(12-7-8)13-5-3-11-4-6-13/h1-2,7,11H,3-6H2,(H,14,15)
278803-18-2Relevant academic research and scientific papers
BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF
-
, (2021/11/13)
The present disclosure provides bifunctional compounds as HPK1 degraders via ubiquitin proteosome pathway, and method for treating diseases modulated by HPK1.
Nicotinic acid derivatives and pharmaceutical compositions comprising same
-
, (2008/06/13)
Compounds are disclosed of the formula STR1 wherein R1 is hydrogen or C1 -C6 alkyl; Y is --CH2 --, --O--, STR2 R2 is C1 -C6 alkyl; C2 -C6 alkenyl; C3 -C6 cycloalkyl; phenyl which may be mono- or di-substituted on the phenyl ring with C1 -C6 alkoxy; aralkyl which may be mono- or di-substituted on the aromatic ring with C1 -C6 alkoxy; diphenylmethyl; carboalkoxy; or an O- or N-heterocyclic radical which is linked to the nitrogen atom via carbonyl or carbonylmethylene; m is 2 or 3; and n is 0 or 1, and physiologically acceptable acid addition salts thereof. The compounds of formula (I) are of a blood flow-increasing action and can be used for the therapy or prevention of diseases in the cardiovascular system.
